- Home
- SNTI vs ATER Comparison
SNTI vs ATER Comparison
Compare SNTI & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ATER
- Stock Information
- Founded
- SNTI 2016
- ATER 2014
- Country
- SNTI United States
- ATER United States
- Employees
- SNTI N/A
- ATER N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ATER Home Furnishings
- Sector
- SNTI Health Care
- ATER Consumer Discretionary
- Exchange
- SNTI Nasdaq
- ATER Nasdaq
- Market Cap
- SNTI 21.3M
- ATER 22.8M
- IPO Year
- SNTI N/A
- ATER N/A
- Fundamental
- Price
- SNTI $3.96
- ATER $2.06
- Analyst Decision
- SNTI Strong Buy
- ATER Strong Buy
- Analyst Count
- SNTI 1
- ATER 1
- Target Price
- SNTI $12.00
- ATER N/A
- AVG Volume (30 Days)
- SNTI 30.3K
- ATER 80.8K
- Earning Date
- SNTI 03-20-2025
- ATER 03-11-2025
- Dividend Yield
- SNTI N/A
- ATER N/A
- EPS Growth
- SNTI N/A
- ATER N/A
- EPS
- SNTI N/A
- ATER N/A
- Revenue
- SNTI N/A
- ATER $107,193,000.00
- Revenue This Year
- SNTI $11.52
- ATER N/A
- Revenue Next Year
- SNTI $78.57
- ATER $5.47
- P/E Ratio
- SNTI N/A
- ATER N/A
- Revenue Growth
- SNTI N/A
- ATER N/A
- 52 Week Low
- SNTI $1.52
- ATER $0.23
- 52 Week High
- SNTI $16.94
- ATER $3.95
- Technical
- Relative Strength Index (RSI)
- SNTI 45.36
- ATER 41.40
- Support Level
- SNTI $3.92
- ATER $2.10
- Resistance Level
- SNTI $4.50
- ATER $2.31
- Average True Range (ATR)
- SNTI 0.26
- ATER 0.18
- MACD
- SNTI -0.03
- ATER -0.00
- Stochastic Oscillator
- SNTI 20.59
- ATER 31.25
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.